Skip to main content
. 2018 Feb 22;16(2):e2003693. doi: 10.1371/journal.pbio.2003693

Fig 3. Coverage probability plotted against the number of participating laboratories for N = 12 (blue), N = 24 (orange), and N = 48 (grey) for simulated studies for 12 additional intervention studies of mouse models of stroke, myocardial infarction, and breast cancer.

Fig 3

First row: tPA, trastuzumab, FK506, rosiglitazone 2, IL-1RA, cardiosphere DC; second row: estradiol, human MSC, MK-80, TMZ, c-kit CSC, rat BMSC (see Table A in S1 Text for details). BMSC, bone marrow stem cell; CSC, cardiac stem cell; DC, derived cell; IL1-RA, interleukin 1 receptor antagonist; MSC, mesenchymal stem cell; TMZ, temozolomide; tPA, tissue plasminogen activator.